← Open Payments lookup

HALI MILLER: Open Payments

NPI 1700330396 · BOGALUSA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$348 in 14 payments from 6 companies in 2025. Trend: 2023 $299 · 2024 $7,308 · 2025 $348

Food & beverage: $243Education: $104
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.7$200
Neurocrine BioSciences, Inc.3$86
Lundbeck LLC1$16
Otsuka America Pharmaceutical, Inc.1$16
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$15
E.R. Squibb & Sons, L.L.C.1$14

Products named: INGREZZA, UZEDY, AUSTEDO XR, ABILIFY ASIMTUFII, CAPLYTA, COBENFY.

Industry payments across LA — which companies pay providers there.